Genetic abnormalities responsible for dilated cardiomyopathy.
- Published in:
- Current Cardiology Reports, 2000, v. 2, n. 5, p. 475, doi. 10.1007/s11886-000-0063-9
- By:
- Publication type:
- Article
Works matching IS 15233782 AND DT 2000 AND VI 2 AND IP 5
Results: 18
1
2
Asymptomatic left ventricular dysfunction in the community.
- Published in:
- Current Cardiology Reports, 2000, v. 2, n. 5, p. 470, doi. 10.1007/s11886-000-0062-x
- By:
- Publication type:
- Article
3
Diastolic heart failure in the community.
- Published in:
- Current Cardiology Reports, 2000, v. 2, n. 5, p. 461, doi. 10.1007/s11886-000-0061-y
- By:
- Publication type:
- Article
4
The role of fibric acid derivatives in the secondary prevention of coronary heart disease.
- Published in:
- Current Cardiology Reports, 2000, v. 2, n. 5, p. 452, doi. 10.1007/s11886-000-0060-z
- By:
- Publication type:
- Article
5
The Gruppo Italiano per lo Studio della Sopravvivenza nell’infarto miocardio (GISSI)-Prevenzione trial on fish oil and vitamin E supplementation in myocardial infarction survivors.
- Published in:
- Current Cardiology Reports, 2000, v. 2, n. 5, p. 445, doi. 10.1007/s11886-000-0059-5
- By:
- Publication type:
- Article
6
Primary prevention of coronary heart disease: Implications of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
- Published in:
- Current Cardiology Reports, 2000, v. 2, n. 5, p. 439, doi. 10.1007/s11886-000-0058-6
- By:
- Publication type:
- Article
7
Implications of the Atorvastatin.
- Published in:
- Current Cardiology Reports, 2000, v. 2, n. 5, p. 433, doi. 10.1007/s11886-000-0057-7
- By:
- Publication type:
- Article
8
Global risk assessment for lipid therapy to prevent coronary heart disease.
- Published in:
- Current Cardiology Reports, 2000, v. 2, n. 5, p. 424, doi. 10.1007/s11886-000-0056-8
- By:
- Publication type:
- Article
9
Clinical trials report.
- Published in:
- Current Cardiology Reports, 2000, v. 2, n. 5, p. 421, doi. 10.1007/s11886-000-0055-9
- By:
- Publication type:
- Article
10
Issues and challenges with antithrombotic therapy in diabetic patients with acute coronary syndromes.
- Published in:
- Current Cardiology Reports, 2000, v. 2, n. 5, p. 411, doi. 10.1007/s11886-000-0054-x
- By:
- Publication type:
- Article
11
Treatment strategies for microvascular dysfunction following acute myocardial infarction.
- Published in:
- Current Cardiology Reports, 2000, v. 2, n. 5, p. 405, doi. 10.1007/s11886-000-0053-y
- By:
- Publication type:
- Article
12
Novel inhibitors of factor X for use in cardiovascular diseases.
- Published in:
- Current Cardiology Reports, 2000, v. 2, n. 5, p. 395, doi. 10.1007/s11886-000-0052-z
- By:
- Publication type:
- Article
13
Antithrombotic therapy in the cardiac catheterization laboratory: Focus on antiplatelet agents.
- Published in:
- Current Cardiology Reports, 2000, v. 2, n. 5, p. 386, doi. 10.1007/s11886-000-0051-0
- By:
- Publication type:
- Article
14
Platelet activation in acute myocardial infarction and the rationale for combination therapy.
- Published in:
- Current Cardiology Reports, 2000, v. 2, n. 5, p. 378, doi. 10.1007/s11886-000-0050-1
- By:
- Publication type:
- Article
15
Clinical trials report.
- Published in:
- Current Cardiology Reports, 2000, v. 2, n. 5, p. 369, doi. 10.1007/s11886-000-0048-8
- By:
- Publication type:
- Article
16
Literature alert.
- Published in:
- 2000
- Publication type:
- Abstract
17
Web alert.
- Published in:
- Current Cardiology Reports, 2000, v. 2, n. 5, p. 361, doi. 10.1007/s11886-000-0046-x
- Publication type:
- Article
18
Oral platelet glycoprotein IIb/IIIa inhibition.
- Published in:
- Current Cardiology Reports, 2000, v. 2, n. 5, p. 372, doi. 10.1007/s11886-000-0049-7
- By:
- Publication type:
- Article